No wonder why SP hit rock bottom.

But absence of proof doesnt mean proof of absence. There are many collaborators. Some are moving and they might yield interesting results.

• Neuramedy
• Janssen
• Oxyrane
• Aposense
• Chiesi
• Daiichi Sankyo

Short list that we're aware of. You never know for sure, plus one breakthrough and the company can double or triple easily.

Risky, but there's some upside.